Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab
Alex K. Bryant, K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, Victoria Daniel, David J. Elliott, Nithya Ramnath, Michael D. Green
Topics & Concepts
DurvalumabMedicineHazard ratioInternal medicineOncologyLung cancerStage (stratigraphy)AdjuvantConfidence intervalCancerImmunotherapyNivolumabBiologyPaleontologyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Research Studies